The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
1 of 6 cited sources checked · 0 supported · 0 flagged · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passes- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesThe quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Normal and diabetic group sizes are reversed for the CIGMA comparison
MinorThe methods say the CIGMA comparison used 12 normal subjects and 11 diabetic patients, but the results report 11 normal subjects and 12 diabetic subjects.
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 28,201–28,300 of 31,469
Lin, Y.-H., & Huang, H. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s201526 · Cited by 2
Diabetes risk score for identifying cardiometabolic risk factors in adult Bangladeshi population
Bhowmik, B., Siddiquee, T., Mujumder, A., et al. (2018) · Journal of Diabetology · doi:10.4103/jod.jod_29_18 · Cited by 1
Evaluation of Some Biochemical Markers in Patient's with Polycystic Ovarian Syndrome
Al-Jumaili, F. T. O., Naji, A. J., & Jasim, T. M. (2015) · Journal of Biotechnology Research Center · doi:10.24126/jobrc.2015.9.2.433 · Cited by 1
Obesity and atrial fibrillation
Jug, J., Čilić, M., Benčić, M. L., Matovinović, M., & Prkačin, I. (2019) · Cardiologia Croatica · doi:10.15836/ccar2019.174 · Cited by 1
Ko, H. J., Kim, J. H., & Kim, M. J. (2019) · Journal of the East Asian Society of Dietary Life · doi:10.17495/easdl.2019.6.29.3.238 · Cited by 1
A dystrophia myotonica 1-es típusának sokszervi megjelenése
Varga, D., & Pál, E. (2019) · Orvosi Hetilap · doi:10.1556/650.2019.31505 · Cited by 1
Shah, R., Subhan, F., Sultan, S. M., Haq, M., Ahmad, H., Khan, Q. R., Ali, G., Ullah, S., & Ullah, I. (2019) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902019000117825 · Cited by 1
Yan, Y., Fan, J.-N., Liu, J., Hu, Y., Ma, J., He, J., Guo, H., Zhang, X., Wang, X., Li, S., et al. (2019) · Mediators of Inflammation · doi:10.1155/2019/3592620 · Cited by 1
Yoon, H. J., Lee, J. H., Gi, M. Y., Cha, J. A., Moon, A. E., & Seong, J.-M. (2019) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2019.0087 · Cited by 1
El-Sayed, H. M., El-Sayd, Z. H., Megahed, T. G. E., et al. (2019) · The Scientific Journal of Al-Azhar Medical Faculty Girls · doi:10.4103/sjamf.sjamf_53_19 · Cited by 1
Reversal of Haemostatic Changes in Letrozole-Induced PCOS Rat Model with Vitamin D Supplementation
MOURSI, M. D. E. E.-B. S., & El-sayed, S. F. (2019) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2019.53961 · Cited by 1
Sirenko, O., & Kuryata, O. V. (2019) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2019-65452 · Cited by 1
HAMID, M. D. E.-H. A. M. M. S. A.-E., & Mehanna, N. S. (2019) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2019.59330 · Cited by 1
Effect of Irisin on Experimentally-Induced Preeclampsia in Female Albino Rats
REHAM H. IBRAHIM, M. D. ;. M. A. H. (2018) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2018.56344 · Cited by 1
KHALIFA, M. D. A. A. K. M. M., MINA J. AYAD, M. S. ;. H. F., & MAHMOUD R. MOHAMED, M. D. (2018) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2018.59606 · Cited by 1
Modulation of Renal Aquaporin-3 by Swimming Exercise in Fructose Induced Metabolic Syndrome
GHADA S. AMER, M. D. ;. D. R. A.-S. (2018) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2018.62819 · Cited by 1
Long Term Effects of Metformin in a Non-Diabetic Population with Differentiated Thyroid Carcinoma
Monti, E., Balestra, M., Michele, M. N., Stefano, G., Conte, L., & Giusti, M. (2019) · Journal of Endocrinology and Diabetes · doi:10.15226/2374-6890/6/3/001133 · Cited by 1
Tahmasebi, W., Alizadeh, R., Nourshahi, M., et al. (2019) · Journal of Kermanshah University of Medical Sciences · doi:10.5812/jkums.96932 · Cited by 1
Soliman, A. F., Abdel-Rahman, M. A., Hamad, H., Eltamany, E. H. M., & Al-Sherbini, A.-S. (2019) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2019.18861.2159 · Cited by 1
Garmendia, F., Álvarez, R. P., Damas, W. T., Valqui, W., & -Muñoz, Y. M. (2019) · Anales de la Facultad de Medicina · doi:10.15381/anales.v80i4.17252 · Cited by 1
Are α-tocopherol levels associated with improved glycaemia?
Bi, X., Loo, Y. T., Yeo, P. L. Q., et al. (2019) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2020.100110 · Cited by 1
Rezaiian, F., Nikooyeh, B., & Neyestani, T. R. (2020) · Nutrition and Food Sciences Research · doi:10.29252/nfsr.7.1.1 · Cited by 1
Screening of insulin resistance in patients with hemodialysis
Rumyantsev, A. S., Filiniuk, P. Y., Коростелева, Н. Ю., & Panina, I. Y. (2020) · Nephrology (Saint-Petersburg) · doi:10.36485/1561-6274-2020-24-1-51-59 · Cited by 1
Yiğenoğlu, T. N., Kebapçı, M. N., & Özen, H. (2020) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.668754 · Cited by 1
Omura, Y. (2020) · Acupuncture & Electro-Therapeutics Research · doi:10.3727/036012920x15779969212982 · Cited by 1
Fujihara, Y., Hamanoue, N., Akehi, Y., Motonaga, R., Tanaka, T., Iwaya, C., Yano, H., Tanabe, M., Nomiyama, T., & Yanase, T. (2020) · Obesity Science & Practice · doi:10.1002/osp4.413 · Cited by 1
Çelik, N. (2020) · International journal of medical biochemistry/International journal of medical biochemistry : · doi:10.14744/ijmb.2020.68442 · Cited by 1
Muñoz, S. R., Romero-Ortiz, M. C., Vallejo, S. A., Sandoval-Alzate, H. F., Zapata, Y. A., Suárez-Niño, J. S., Maldonado-Acosta, L. M., Vega, R. F., Garcés, M. F., Iglesias-Gamarra, A. D. J., et al. (2020) · Acta Médica Colombiana · doi:10.36104/amc.2020.1323 · Cited by 1
Lee, H. J., Primo, M. Á., Allo, M. Á., et al. (2025) · Revista Argentina de Cardiología · doi:10.7775/rac.es.v88.i1.17195 · Cited by 1
Çavuşoğlu, T., Darıverenli, E., Vural, K., Ekerbiçer, N., Ulman, C., Ölmez, E., & Uysal, N. (2020) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2019-0224 · Cited by 1
de Luis, D. A., Primo, D., Izaola, O., Gómez, J. J. L., Hoyos, E. G., Ortolá, A., Delgado, E., & Díaz, G. (2020) · Nutrición Hospitalaria · doi:10.20960/nh.02941 · Cited by 1
Mahjabeen, S., Rahman, A. K. M. S., Hossain, M., Mustari, M., Abedin, M., Mahmood, T., Chowdhury, T. I., Islam, T., & Hossain, R. M. (2020) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2020.87005 · Cited by 1
Abdelkarem, A. M., Alamri, A. H., Megeid, B. Y. A., et al. (2018) · PhilPapers (PhilPapers Foundation) · Cited by 1
Psoriasis and insulin resistance
Li, X., Xinran, J., Meng, Y., Li, N., Chunyan, D., Zhengrong, L., & Li, P. (2019) · Huanqiu zhongyiyao · Cited by 1
Vorschlag für neue Subklassifikationen des Diabetes mellitus
Zaharia, O., & Szendrödi, J. (2020) · Aktuelle Kardiologie · doi:10.1055/a-1214-5618 · Cited by 1
Nyenwe, E. A., JAMES, D. J., Wan, J. Y., & Dagogo-Jack, S. E. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa137 · Cited by 1
Association between Insulin Resistance and Benign Prostatic Hyperplasia
Sarkar, S., Saha, A., & Dawn, I. (2020) · International Journal of Human and Health Sciences (IJHHS) · doi:10.31344/ijhhs.v5i2.267 · Cited by 1
Amadi, J. A., Amadi, P. U., Njoku, U. C., & Osuoha, J. O. (2020) · Translational research · doi:10.1016/j.trsl.2020.10.008 · Cited by 1
Protective effect of sitagliptin and whole-body γ-irradiation in diabetes-induced cardiac injury
Mansour, S. M., Aly, S., Hassan, S. H. M., & Zaki, H. F. (2020) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2020-0454 · Cited by 1
Martins, P., Pires, A., Santos, J. L., Sena, C. M., & Seiça, R. M. F. (2020) · Current HIV Research · doi:10.2174/1570162x18999201118155026 · Cited by 1
ALI, M. D. D. A. A. M. A. I., & Ibrahim, M. (2020) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2020.125153 · Cited by 1
Loon, E. V., Aboumsallem, J. P., Lerut, E., Bogojevic, M., Đenić, A., Park, W. D., Muthuramu, I., Mishra, M., Stegall, M. D., Naesens, M., et al. (2020) · Journal of Nephropathology · doi:10.34172/jnp.2021.17 · Cited by 1
Jaccob, A. A., Sheri, F. H., & Aljazaeari, Q. A. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
The Association of Visceral Adiposity Index with Insulin Resistance in Adults with Prediabetes
Morshed, M. S., Haq, T., Fariduddin, M., et al. (2021) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2021.111002 · Cited by 1
Androgens and Cardiovascular Risk Factors in Polycystic Ovary Syndrome
Cardozo, L. L. Y., Huffman, A. M., Pruett, J. E., & Romero, D. G. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96005 · Cited by 1
Urgancı, N., Kalyoncu, D., & Güleç, S. G. (2021) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2020.07.006 · Cited by 1
Gorshunska, M. (2013) · The Ukrainian Biochemical Journal · doi:10.15407/ubj85.03.010 · Cited by 1
Guewo‐Fokeng, M., Sobngwi, E., Atogho‐Tiedeu, B., Lontchi‐Yimagou, E., Chedjou, J.-P., Mbanya, J. C., & Mbacham, W. F. (2021) · Open Journal of Genetics · doi:10.4236/ojgen.2021.112002 · Cited by 2
Do nonobese patients with Behçet’s disease have insulin resistance?
Cebeci, F., Kayataş, K., Erdoğan, S. S., & Onsun, N. (2021) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.14276 · Cited by 1
Odeniyi, I. A., Odife, U. B., Fasanmade, O. A., & Ohwovoriole, A. E. (2021) · Journal of Clinical Sciences · doi:10.4103/jcls.jcls_46_20 · Cited by 1
Pinto, R. M., Fortes, J. S., Monteiro, R. V., Alves, N. S., Curado, M. P., Minasi, L. B., Silva, D. D. M. E., & da Cruz, A. D. (2021) · Obesity Research - Open Journal · doi:10.17140/oroj-8-145 · Cited by 1
Vlachopapadopoulou, E. A., Dikaiakou, E., Anagnostou, E., et al. (2020) · Journal of Obesity and Chronic Diseases · doi:10.17756/jocd.2020-032 · Cited by 1
Kazatseva, K. V., Nagornev, S. N., Фролков, В. К., & Gusakova, E. V. (2021) · Fizioterapevt (Physiotherapist) · doi:10.33920/med-14-2104-06 · Cited by 1
Quan, H., Fang, T., Lin, L., Lü, L., Ou, Q., Zhang, H., Chen, K., & Zhou, Z. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01102-1 · Cited by 1
The Relationship between Insulin Resistance and Spatial QRS-T Angle in American Adults.
Faramawi, M. F., Delhey, L. M., Abouelenein, S., et al. (2021) · PubMed · doi:10.6515/acs.202107_37(4).20210222a · Cited by 1
Kim, K. H., Kim, Y. H., Seo, K. W., Yoon, K. Y., Shin, Y. M., Choi, Y. S., & Kim, B. K. (2021) · Kosin Medical Journal · doi:10.7180/kmj.2021.36.1.25 · Cited by 1
Román, G. S., Guitián, C. C., Sánchez, T. A., et al. (2021) · Revista Habanera de Ciencias Médicas · Cited by 1
Bergman, R. N. (2008) · Obesity · doi:10.1038/oby.2008.52 · Cited by 1
Al-Zeidaneen, S. A., Ahmad, M. N., Al-Ebous, A., & Saudi, R. M. A. (2021) · Forum of Clinical Oncology · doi:10.2478/fco-2019-0018 · Cited by 1
Salman, H. F., Hussain, M. K., & Mohammed, H. J. (2020) · Cited by 1
Tolerance to Glucose and Lipid High Metabolic Reactions After Burns in an Obese Rat Model
Yu, H., Nie, C., Zhou, Y., Wang, X., Wang, H., & Shi, X. (2021) · Journal of Burn Care & Research · doi:10.1093/jbcr/irab163 · Cited by 1
Classer les diabètes qui surviennent chez l’adulte : plus on y pense, plus c’est confus
Monnier, L., & Colette, C. (2021) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2021.09.008 · Cited by 4
Preclinical safety evaluation of drone brood homogenate and justification of pharmacological action
Павлюк, Б. В., Stechyshyn, I., Чубка, М. Б., et al. (2021) · Pharmacia · doi:10.3897/pharmacia.68.e70678 · Cited by 1
Pastusiak, K., Matuszewska, E., Pietkiewicz, D., et al. (2021) · Nutrients · doi:10.3390/nu13113853 · Cited by 1
Choi, H. S., Kim, J. T., Lee, H. K., Park, W. H., Pak, Y. K., & Lee, S. W. (2021) · Endocrinology and Metabolism · doi:10.3803/enm.2021.1226 · Cited by 1
Nabag, W. O. M., Farajalla, E. A., & Sheikh, M. A. E. (2013) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2014/5775 · Cited by 1
Impact of Sex and Lifestyle of Adolescents and Their Parents on Obesity
Yoshinaga, M., Miyazaki, A., Shinomiya, M., et al. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407869-7.00020-9 · Cited by 1
The Relationship Between Remnant-Like Particle (RLP) Cholesterol and Insulin Resistance
Mukaiyama, R., & Nonaka, Y. (2005) · Ningen dock : official journal of the Japanese Society of Human Dry Dock · doi:10.11320/ningendock2005.19.39 · Cited by 1
Xi, W., Gong, F., Liu, W., & Lu, G. (2012) · Chin J Reprod Contracep · doi:10.1016/s1001-7844(13)60002-4 · Cited by 1
Hassan, N. E., El-Masry, S. A., Nageeb, A., Hussieny, M. S. E., Khalil, A., Aly, M. M., Selim, M. K., Alian, K. M., Rasheed, E. A., Wahed, M. M. A., et al. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.7625 · Cited by 1
Clinical significance of leptin in systemic lupus erythematosus
Kondratyeva, L. V., Panafidina, T. A., Попкова, Т. В., et al. (2021) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2021-6-61-66 · Cited by 1
Azeez, T. A. (2021) · Hamdan Medical Journal · doi:10.4103/hmj.hmj_28_21 · Cited by 1
Nosko, N. O., & Харченко, В. В. (2021) · Wiadomości Lekarskie · doi:10.36740/wlek202110212 · Cited by 1
Fuat, İ., Eryilmaz, M., Pekgör, O., et al. (2021) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2011-304 · Cited by 1
Diab, S., Sharaby, C. M., Hamad, H., et al. (2022) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2022.112814.5135 · Cited by 1
Insulin Resistance in Early and Advanced Diabetic Kidney Disease
Purandare, V. B., Kakrani, A. L., Bale, C., et al. (2022) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_7_21 · Cited by 1
Abu-Raghif, A. R., Yaseen, Y. A., & Dawood, M. H. (2019) · Iraqi journal of Medical Sciences · doi:10.22578/ijms.16.4.6 · Cited by 1
Metabolic syndrome in obese adolescents: what is enough?
SEWAYBRICKER, L. E., Antônio, M. Â. R. D. G. M., Mendes, R. T., Filho, A. D. A. B., & Zambon, M. P. (2013) · Revista da Associação Médica Brasileira (English Edition) · doi:10.1016/s2255-4823(13)70431-4 · Cited by 1
Kim, H., Yoon, E., Kim, O., & Kim, E. M. (2022) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes21074 · Cited by 1
Vitamin D deficiency during pregnancy
Todorova, M., Gerova, D. I., & Galunska, B. T. (2022) · Scripta Scientifica Medica · doi:10.14748/ssm.v0i0.7834 · Cited by 1
Improved Insulin Resistance and Glucose Variability by Super-Low Carbohydrate Diet
Urasaki, H., Bando, H., Kobayashi, H., Urasaki, H., Ogawa, H., Nakanishi, M., Watanabe, O., & Nagahiro, S. (2022) · Diabetes Research - Open Journal · doi:10.17140/droj-8-154 · Cited by 1
Tunçay, S. C., Keskınoğlu, A., Bulut, İ. K., et al. (2022) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13846 · Cited by 1
Elpasty, S. S. A., Helal, E. G. E., Algendy, A., et al. (2022) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/2022/3776676 · Cited by 1
The Negative Association Between NAFLD Severity and CKD in a Non-Diabetic Gouty Population
Huang, Y., Zhou, Y., Wang, Y., Chi, J., Lv, W., Wang, Y., & Chen, Y. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1815-7559 · Cited by 1
Saha, A. (2022) · Asian Journal of Medical Sciences · doi:10.3126/ajms.v13i5.44360 · Cited by 1
Early Childhood Contributions to Insulin Resistance
Dunger, D. B., Salgin, B., & Ong, K. K. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_7 · Cited by 1
Aller, R., Gómez, J. J. L., Izaola, O., Primo, D., & de Luis, D. A. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2019.04.002 · Cited by 1
Son, J. S., Chae, S. A., Park, B. I., Du, ., & Song, W. (2019) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2018.12.004 · Cited by 1
Oliveira, L. G., Moreno, L. G., Melo, D. D. S., Costa-Pereira, L. V., Carvalho, M. M. D. F., Evangelista-Silva, P. H., Alves, A. M., Magalhães, F. D. C., Dias‐Peixoto, M. F., & Esteves, E. A. (2021) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pab.1.2021.6 · Cited by 1
Kazem, Y. I., Moaty, M. I. A., Shebini, S. M. E., et al. (2014) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2014.047 · Cited by 1
de Luis, D. A., Primo, D., Izaola, O., et al. (2020) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2020.08.004 · Cited by 1
Turgut, S., Acarer, D., Seyit, H., Pamuk, N., Pişkinpaşa, H., Bozkur, E., Karabulut, M., & Çakır, İ. (2022) · Hormone and Metabolic Research · doi:10.1055/a-1856-7014 · Cited by 1
Badawi, R., Watany, M. M., Elsabagh, H. M., et al. (2022) · The Open Biomarkers Journal · doi:10.2174/18753183-v12-e2204040 · Cited by 1
Khan, S. H., Afzal, A. H., Shahid, R., & Manzoor, R. (2022) · The Professional Medical Journal · doi:10.29309/tpmj/2022.29.06.6590 · Cited by 1
Takahara, M., Shiraiwa, T., Maeno, Y., Yamamoto, K., Shiraiwa, Y., Yoshida, Y., Nishioka, N., Katakami, N., & Shimomura, I. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01064-w · Cited by 1
Cardio-metabolic risk modeling and assessment through sensor-based measurements
Giorgi, D., Bastiani, L., Morales, M. A., Pascali, M. A., Colantonio, S., & Coppini, G. (2022) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2022.104823 · Cited by 2
Torabi, M., & Mirzaei, B. (2022) · Journal of Sport and Exercise Physiology · doi:10.52547/joeppa.15.3.81 · Cited by 1
Solak, G. T. V., Akkuş, G., Solak, Y., Köse, S., & Sert, M. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2022.2096876 · Cited by 1
Taghipour, R., Mahmoudabadi, A. Z., Jangravi, Z., Javadi, H., Osqueei, M. R., Mousavi, N., & Raeeszadeh, M. (2021) · Journal of North Khorasan University of Medical Sciences · doi:10.52547/nkums.13.3.43 · Cited by 1
Serhiyenko, V. A. (2019) · Advanced Biomedicine · doi:10.54730/abm.2019.010204 · Cited by 1
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
